3 results
Approved WMOCompleted
The primary objective is to determine the effectiveness of RSWT versus FSWT in treating patellar tendinopathy.
Approved WMOCompleted
To evaluate the safety and tolerability of XXB750 in adult participants with chronic stable HFrEF/HFmrEF.
Approved WMOCompleted
To characterize the safety, tolerability, and recommended phase 2 dose (RP2D) of each combination partner used with ruxolitinib (Part 1)To evaluate the preliminary efficacy of each novel ruxolitinib combination treatment arm (Parts 2 & 3)